Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;97(1153):742-743.
doi: 10.1136/postgradmedj-2020-138447. Epub 2020 Aug 26.

Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures

Affiliations
Comment

Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures

Tauqeer Hussain Mallhi et al. Postgrad Med J. 2021 Nov.
No abstract available

Keywords: Immunology; Infectious diseases; Medical journalism; Virology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

References

    1. AlAkhras A, AlMessabi AH, Abuzeid H, et al. Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?: the fellowship of postgraduate medicine; 2020. - PMC - PubMed
    1. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama. 2020 May 12;323(18):1824–36. - PubMed
    1. Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. Br Med J Pub Group 2020;m1432. - PubMed
    1. Caly L, Druce JD, Catton MG, et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020:104787. - PMC - PubMed
    1. Andreani J, Le Bideau M, Duflot I, et al. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microbial pathogenesis 2020:104787. - PMC - PubMed

Substances